Cargando…

Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective

Evidence from a few small randomized trials and retrospective cohorts mostly including various tumor entities indicates a prolongation of disease free survival (DFS) and overall survival (OS) from local ablative therapies in oligometastatic disease (OMD). However, it is still unclear which patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piroth, Marc D., Krug, David, Feyer, Petra, Baumann, René, Combs, Stephanie, Duma, Marciana-Nona, Dunst, Jürgen, Fastner, Gerd, Fietkau, Rainer, Guckenberger, Matthias, Haase, Wulf, Harms, Wolfgang, Hehr, Thomas, Sedlmayer, Felix, Souchon, Rainer, Strnad, V., Budach, Wilfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217902/ https://www.ncbi.nlm.nih.gov/pubmed/35527272 http://dx.doi.org/10.1007/s00066-022-01938-x

Ejemplares similares

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
por: Krug, David, et al.
Publicado: (2021)

Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
por: Piroth, Marc D., et al.
Publicado: (2020)

Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention
por: Piroth, Marc D., et al.
Publicado: (2018)

Current controversies in radiotherapy for breast cancer
por: Krug, David, et al.
Publicado: (2017)

DEGRO practical guideline for partial-breast irradiation
por: Strnad, V., et al.
Publicado: (2020)

DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences
por: Harms, Wolfgang, et al.
Publicado: (2016)

DEGRO practical guidelines: radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer
por: Sedlmayer, F., et al.
Publicado: (2013)

Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries
por: Duma, Marciana Nona, et al.
Publicado: (2017)

Das Lymphödemrisiko von Mammakarzinompatientinnen nach Operation oder Strahlentherapie der Axilla
por: Duma, Marciana-Nona
Publicado: (2021)

Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020)

Kardioonkologie: Herzdosis während einer Radiotherapie im Thoraxbereich
por: Duma, Marciana-Nona, et al.
Publicado: (2021)

Ösophaguskarzinom: Prognoseverbesserung durch neoadjuvante Radiochemotherapie
por: Knippen, Stefan, et al.
Publicado: (2021)

Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?
por: Münch, Stefan, et al.
Publicado: (2017)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy
por: Oechsner, Markus, et al.
Publicado: (2015)

Registration uncertainties between 3D cone beam computed tomography and different reference CT datasets in lung stereotactic body radiation therapy
por: Oechsner, Markus, et al.
Publicado: (2016)

Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data
por: Borm, Kai Joachim, et al.
Publicado: (2018)

Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors
por: Dreher, Constantin, et al.
Publicado: (2018)

Deep inspiration breath-hold for left-sided breast irradiation: Analysis of dose-mass histograms and the impact of lung expansion
por: Oechsner, Markus, et al.
Publicado: (2019)

Impact of (18)F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients
por: Münch, Stefan, et al.
Publicado: (2020)

Oligometastasis: More Lessons to Be Learned
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer
por: Kurrumeli, Drilon, et al.
Publicado: (2020)

Metastasis-directed therapy for oligometastasis and beyond
por: Beckham, Thomas H., et al.
Publicado: (2020)

A novel setup approach for helical tomotherapy in head and neck cancer: A case report
por: DUMA, MARCIANA NONA, et al.
Publicado: (2013)

Tangential Field Radiotherapy for Breast Cancer—The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?
por: Duma, Marciana Nona, et al.
Publicado: (2017)

Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting
por: Devecka, Michal, et al.
Publicado: (2020)

MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease
por: Mayinger, Michael, et al.
Publicado: (2019)

Breast clinical target volume: HU-based glandular CTVs and ESTRO CTVs in modern and historical radiotherapy treatment planning
por: Duma, Marciana Nona, et al.
Publicado: (2021)

MicroRNA Expression Characterizes Oligometastasis(es)
por: Lussier, Yves A., et al.
Publicado: (2011)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Oligometastasis: Expansion of Curative Treatments in the Field of Oncology
por: Lim, Ah Reum, et al.
Publicado: (2023)

Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?
por: Mayinger, Michael, et al.
Publicado: (2019)

Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients
por: Borm, Kai Joachim, et al.
Publicado: (2019)

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
por: Zehentmayr, Franz, et al.
Publicado: (2020)

Oligometastasis and oligo-recurrence: more than a mirage
por: Huang, Fang, et al.
Publicado: (2014)

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
por: Mazzola, Rosario, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dl3kps10afdukc24gcplbat7ch